November 2020

NEUROSCIENCES

EXAMINING THE FREQUENT NEUROLOGIC MANIFESTATIONS AND ENCEPHALOPATHY-ASSOCIATED MORBIDITY IN COVID-19 PATIENTS

Featuring: Igor Koralnik, MD

Episode Summary

A study led by Igor Koralnik, MD, chief of Neuro-infectious Disease and Global Neurology in the Department of Neurology, found that 32 percent of hospitalized COVID-19 patients experienced encephalopathy, leading to significantly worse outcomes. The Northwestern Medicine study, published in the Annals of Clinical and Translational Neurology, is the first to examine the frequency and severity of neurologic manifestations in patients hospitalized with COVID-19 in the United States. In this episode of Better Edge, Koralnik, who also leads Northwestern Medicine's Neuro COVID-19 Clinic, explains the results of the study and discusses his clinic's unique approach to treating COVID-19 "long haulers."
Igor Koralnik, MD is the Chief of Neuro-infectious Disease and Global Neurology in the Department of Neurology. 

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like